학술논문
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
Document Type
Article
Author
Chataway, Jeremy; Gandini Wheeler-Kingshott, Claudia A.M.; De Angelis, Floriana; Plantone, Domenico; Doshi, Anisha; John, Nevin; Williams, Thomas; Braisher, Marie; Beyene, Tiggy; Bassan, Vanessa; Zapata, Alvin; Chandran, Siddharthan; Connick, Peter; Lyle, Dawn; Cameron, James; Mollison, Daisy; Colville, Shuna; Dhillon, Baljean; Weir, Christopher J.; Parker, Richard A.; Ross, Moira; Cranswick, Gina; Giovannoni, Gavin; Gnanapavan, Sharmilee; Nicholas, Richard; Rashid, Waqar; Aram, Julia; Ford, Helen; Overell, James; Young, Carolyn; Arndt, Heinke; Duddy, Martin; Guadagno, Joe; Evangelou, Nikolaos; Craner, Matthew; Palace, Jacqueline; Hobart, Jeremy; Sharrack, Basil; Paling, David; Hawkins, Clive; Kalra, Seema; McLean, Brendan; Stallard, Nigel; Bastow, Roger; Parker, Richard A; Stutters, Jonathan; MacManus, David; Prados Carrasco, Ferran; Barkhof, Frederik; Ourselin, Sebastien; Pavitt, Sue H; Gandini Wheeler-Kingshott, Claudia Angela; Weir, Christopher J
Source
In The Lancet Neurology March 2020 19(3):214-225
Subject
Language
ISSN
1474-4422